HTA5 Variation in Health Technology Assessments for Nivolumab Plus Chemotherapy Vs Chemotherapy in First-Line Gastric Cancer
Abstract
Authors
D. Bertwistle P. Casabianca L. Donvovan P† Huetson G. Okorogheye E. Theodorou E. Vezina J. Villeneuve M.R. Yoon